1-methyl-3-(phenylamino)quinolin-1-ium iodide | 951647-76-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-methyl-3-(phenylamino)quinolin-1-ium iodide
• 英文别名: 1-methyl-3-(phenylamino)quinolinium iodide；1-methyl-N-phenylquinolin-1-ium-3-amine;iodide
• CAS: 951647-76-0
• 化学式: C₁₆H₁₅N₂*I
• 分子量: 362.213
• InChiKey: QFILJWZGCUMPET-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  0.41
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  15.9
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  苯基喹啉-3-基-胺 、 碘甲烷 以 1,4-二氧六环 为溶剂， 反应 8.0h， 生成 1-methyl-3-(phenylamino)quinolin-1-ium iodide
  参考文献：
  名称：

  抗植物病原真菌隐山葵衍生物的设计，合成及抗真菌评价

  摘要：

  受天然来源的多种衍生物的广泛抗植物病原学应用的启发，随后设计，合成并评价了隐山平及其衍生物对四种农业重要真菌solani Rhizoctonia solani，Botrytis cinerea，Fusarium graminearum和Sclerotiorum sclerotiorum的抗真菌活性。体外测定结果表明，化合物a1-a24对灰葡萄孢具有很好的杀菌作用（EC 50 <4μg/ mL）。特别是a3的EC 50表现出明显的抑制活性0.027μg/ mL。在追求进一步扩大cryptolepine的抗真菌谱，开环化合物F1产生更好的活性与EC 50的3.632微克/毫升抗水稻纹枯病菌和EC 50 5.599微克/毫升的抗禾谷镰孢。此外，选择a3作为研究其对灰葡萄孢菌的初步抗真菌机制的候选者，这表明不仅有效抑制了孢子萌发，严重破坏了菌丝体的正常生理结构，而且明显地积累了有害的活性氧，并且正

  DOI：

  10.1021/acs.jafc.0c06480

文献信息

• Structure–Activity Relationship for Small Molecule Inhibitors of Nicotinamide<i>N</i>-Methyltransferase
  作者：Harshini Neelakantan、Hua-Yu Wang、Virginia Vance、Jonathan D. Hommel、Stanton F. McHardy、Stanley J. Watowich

  DOI：10.1021/acs.jmedchem.7b00389

  日期：2017.6.22

  biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics. We have identified small molecule inhibitors of NNMT with >1000-fold range of activity and developed comprehensive structure–activity relationships (SARs) for NNMT inhibitors. Screening of N-methylated quinolinium, isoquinolinium, pyrididium, and benzimidazolium/benzothiazolium analogues resulted in the

  烟酰胺N-甲基转移酶（NNMT）是一种基本的胞质生物转化酶，可催化内源性和外源性异源生物的N-甲基化。我们已经确定了具有> 1000倍活性范围的NNMT小分子抑制剂，并为NNMT抑制剂开发了全面的结构-活性关系（SAR）。筛选N-甲基化的喹啉鎓，异喹啉鎓，吡啶鎓和苯并咪唑鎓/苯并噻唑鎓类似物导致鉴定出喹啉鎓是极有希望的具有极低摩尔浓度的支架（IC 50〜1μM）NNMT抑制。基于抑制剂的计算机对接至NNMT底物（烟酰胺）的结合位点在配体-酶相互作用对接得分与实验计算的IC 50值之间产生了稳固的相关性。预测的喹啉类似物的结合方向揭示了与NNMT底物结合位点残基的选择性结合以及驱动蛋白质-配体分子间相互作用和NNMT抑制的基本化学特征。这一新系列的小分子NNMT抑制剂的开发指导了类药物前体抑制剂的未来设计，以治疗以NNMT活性异常为特征的几种代谢和慢性疾病。
• Antifungal and antiparasitic indoloquinoline derivates
  申请人：Ablordeppey Y. Seth

  公开号：US20070232640A1

  公开（公告）日：2007-10-04

  A compound having the formula: wherein: R is an electron withdrawing or electron donating moiety; R 5 and R 10 may be the same or different and are a straight or branched 1-5 carbon or heteroatom chain substituted terminally by a cycloalkyl or aromatic ring, or other structural isomer or complex thereof; n is the position of substitution of R; Z is N—R 10 , O, S, S═O, CH 2 or C═O; y is 1-5 and Q is Z or NH, with the proviso that, where Z is NH, N—CH 3 , S or O and R n is H, R 5 may not be CH 3 ; as well as quaternary ammonium salts thereof and their use as pharmacological compositions and for methods of treatment.

  具有以下化学式的化合物： 其中：R是一个电子受体或电子给予基团； R5和R10可以相同也可以不同，是一条直链或支链的1-5碳或杂原子链，在末端被环烷基或芳香环取代，或其他结构异构体或其复合物；n是R的取代位置； Z是N—R10，O，S，S═O，CH2或C═O；y为1-5，Q为Z或NH， 但是，如果Z为NH，N—CH3，S或O，且Rn为H，则R5可能不是CH3；以及其季铵盐和它们作为药物组合物的用途和治疗方法。
• Antifungal and Antiparasitic Indoloquinoline Derivatives
  申请人：Ablordeppey Seth Y.

  公开号：US20120157493A1

  公开（公告）日：2012-06-21

  “An indoloquinoline wherein the quarternary N-5 atom is a straight C(1-5) chain, a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring; the 10 position is N—R 10 , O, S, S═O, CH 2 , or C═O, where R 10 is a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring. In one embodiment the quarternary N-5 atom is —CH 3 and the 10 position is N—(CH 2 ) 5 -Ph.”

  “一种吲哚喹啉，其中季铵N-5原子是直链C（1-5）链，分支C（1-5）链，杂原子链，末端被环烷基或芳香环取代的直链，末端被环烷基或芳香环取代的分支链，末端被环烷基或芳香环取代的杂原子链; 10位是N-R10，O，S，S═O，CH2或C═O，其中R10是分支C（1-5）链，杂原子链，末端被环烷基或芳香环取代的直链，末端被环烷基或芳香环取代的分支链，末端被环烷基或芳香环取代的杂原子链。在一种实施例中，季铵N-5原子是-CH3，而10位是N-（CH2）5-Ph。”
• Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens
  作者：Tryphon K. Mazu、Jagan R. Etukala、Xue Y. Zhu、Melissa R. Jacob、Shabana I. Khan、Larry A. Walker、Seth Y. Ablordeppey

  DOI：10.1016/j.bmc.2010.10.065

  日期：2011.1

  Previous studies on the indoloquinoline alkaloid, cryptolepine (2), revealed that it has antii-nfective properties among other activities. Using Structure-activity relationship (SAR) techniques, several ring-opened analogs of cryptolepine (3-phenylaminopyridinium and 3-phenylaminoquinolinium derivatives) were designed to improve the potency and lower the cytotoxicity shown by several of the precursor agents. Results indicate that these ring-opened analogs constitute new anti-infective agents with over a 100-fold potency and several fold lower cytotoxicity than cryptolepine from which they are derived. Published by Elsevier Ltd.
• US8158646B2
  申请人：——

  公开号：US8158646B2

  公开（公告）日：2012-04-17